-
-
-
-
-
-
-
DexCom (DXCM) PT Lowered to $80 at BofA Securities
-
-
-
-
-
-
-
Benchmark Starts DexCom (DXCM) at Buy
-
-
-
-
-
-
-
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
-
-
-
-
-
-
-
Barclays Downgrades DexCom (DXCM) to Underweight
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Jabil (JBL)
-
-
-
-
-
-
-
'DexCom (DXCM) Too Cheap to Ignore'; Stock PT Lowered at Bernstein
-
-
-
-
-
-
-
DexCom (DXCM) Mentioned Cautiously Again at Hunterbrook
-
412,130 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

